Palliative Strahlentherapie: Die metastatisch bedingte Rückenmarkskompression

Zusammenfassung

Ziel Diskutiert wird die nach derzeitigem Stand optimale Therapie der metastatisch bedingten Rückenmarkskompression (MBRK) unter Berücksichtigung der aktuellen Literatur. Methodik Es wird der Stellenwert der alleinigen Strahlentherapie (RT) sowie der Operation mit nachfolgender Bestrahlung unter Berücksichtigung der Überlebensprognose, des Primärtumors und der Ausdehnung der Metastasierung erörtert. Ferner werden die relevanten Prognosefaktoren hinsichtlich motorischer Funktion nach RT, lokaler Kontrolle und Gesamtüberleben beschrieben. Ergebnisse und Schlussfolgerungen Die alleinige RT ist die häufigste Therapie der MBRK. Eine zusätzliche Operation ist nur bei ausgewählten Patienten in gutem Allgemeinzustand und guter Überlebensprognose indiziert. Patienten mit strahlensensiblen Tumoren (Plasmozytome/Lymphome), insbesondere Patienten mit Oligometastasierung, sollten nach Möglichkeit nicht operiert werden. Die Langzeit-RT führt bei Patienten mit Plasmozytom, Mammakarzinom oder Prostatakarzinom zu besserer lokaler Kontrolle als die Kurzzeit-RT. Plasmozytompatienten sollten immer eine Langzeit-RT erhalten, da diese zu einer besseren motorischen Funktion führt als eine Kurzzeit-RT. Eine Kurzzeit-RT sollte bei Patienten mit anderen Primärtumoren als einem Plasmozytom/Lymphom und einer Lebenserwartung < 6 Monaten eingesetzt werden. Das Überleben kann mithilfe eines neu entwickelten Scores abgeschätzt werden.

Abstract

Background The optimal treatment of metastatic spinal cord compression (MSCC) is discussed considering the current literature. Material and methods The role of radiotherapy (RT) and of surgery followed by radiotherapy considering survival prognosis, primary tumor, and extension of metastatic disease is described. Relevant prognostic factors regarding motor function, local control, and overall survival are presented. Results and conclusions RT alone is the most common treatment of MSCC. Additional surgery is indicated only for selected patients with good performance status and favorable survival prognosis. Patients with radiosensitive tumors (myeloma/lymphoma), in particular those with oligometastatic disease, should generally not receive surgery. Long-course-RT results in better local control than short-course-RT in patients with myeloma, breast cancer, or prostate cancer. Myeloma patients should always receive long-course-RT, as it is associated with better functional outcome than short-course RT. Short-course-RT should be used in patients with primary tumors other than myeloma/lymphoma and expected survival < 6 months. Survival can be estimated with a recently developed score.

metastatisch bedingte Rückenmarkskompression - motorische Funktion - lokale Kontrolle - Gesamtüberleben

metastatic spinal cord compression - motor function - local control - survival

Literatur

• 1 Bach F, Larsen B H, Rohde K. et al . Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations, and prognosis in 398 patients with spinal cord compression.  Acta Neurochir. 1990;  107 37-43
• 2 Loblaw D A, Laperriere N J, Mackillop W J. A population-based study of malignant spinal cord compression in Ontario.  Clin Oncol. 2003;  15 211-217
• 3 Kato A, Ushio Y, Hayakawa T, Yamada K, Ikeda H, Mogami H. Circulatory disturbance of the spinal cord with epidural neoplasms in rats.  J Neurosurg. 1985;  63 260-265
• 4 Manabe S, Tanaka H, Higo Y, Park P, Ohno T, Tateishi A. Experimental analysis of the spinal cord compressed by spinal metastasis.  Spine. 1989;  14 1308-1315
• 5 Ushio Y, Posner R, Posner J B, Shapiro W R. Experimental spinal cord compression by epidural neoplasms.  Neurology. 1977;  27 422-429
• 6 Tarlov I, Klinger H. Spinal cord compression studies. II. Time limits for recovery after acute compression in dogs.  AMA Arch Neurol Psychiatry. 1954;  71 271-290
• 7 Tarlov I, Klinger H, Vitale S. Spinal cord compression studies. I. Experimental techniques to produce acute and gradual compression.  AMA Arch Neurol Psychiatry. 1953;  70 813-819
• 8 Rades D, Heidenreich F, Karstens J H. Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression.  Int J Radiat Oncol Biol Phys. 2002;  53 975-979
• 9 Colletti P M, Siegel H J, Woo M Y, Young H Y, Terk M R. The impact on treatment planning of MRI of the spine in patients suspected of vertebral metastasis: an efficacy study.  Comput Med Imaging Graph. 1996;  20 159-162
• 10 Li K C, Poon P Y. Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of vertebrae.  Magn Reson Imaging. 1988;  6 547-556
• 11 Rades D, Bremer M, Goehde S, Jorgensen M, Kartsens J H. Spondylodiscitis in patients with spinal cord compression: a possible pitfall in radiation oncology.  Radiother Oncol. 2001;  59 307-309
• 12 Gilbert R W, Kim J H, Posner R B. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment.  Ann Neurol. 1978;  3 40-51
• 13 Helweg-Larsen S, Sørensen P S, Kreiner S. Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients.  Int J Radiat Oncol Biol Phys. 2000;  46 1163-1169
• 14 Kovner F, Spigel S, Rider I. et al . Radiation therapy of metastatic spinal cord compression. Multidisciplinary team diagnosis and treatment.  J Neurooncol. 1999;  42 85-92
• 15 Tomita T, Galicich J H, Sundaresan N. Radiation therapy for spinal epidural metastases with complete block.  Acta Radiol Oncol. 1983;  22 135-143
• 16 Baskin D S. Spinal cord injury. In: Ewans RW (ed) Neurology and trauma. Philadelphia; Saunders 1996: 276-299
• 17 Patchell R, Tibbs P A, Regine W F. et al . Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial.  Lancet. 2005;  366 643-648
• 18 Prasad D, Schiff D. Malignant spinal-cord compression.  Lancet Oncol. 2005;  6 15-24
• 19 Rades D, Stalpers L J, Veninga T. et al . Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.  J Clin Oncol. 2005;  23 3366-3375
• 20 Maranzano E, Bellavita R, Rossi R. et al . Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial.  J Clin Oncol. 2005;  23 3358-3365
• 21 Rades D, Fehlauer F, Stalpers L JA. et al . A prospective evaluation of two radiation schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multi-center study.  Cancer. 2004;  101 2687-2692
• 22 Koswig S, Budach V. Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study.  Strahlenther Onkol. 1999;  175 500-508
• 23 Steenland E, Leer J W, van Houwelingen H. et al . The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study.  Radiother Oncol. 1999;  52 101-109
• 24 Helweg-Larsen , Hansen S W, Sørensen P S. Second occurrence of symptomatic metastatic spinal cord compression and findings of multiple spinal epidural metastases.  Int J Radiat Oncol Biol Phys. 1995;  33 595-598
• 25 Hoskin P J, Grover A, Bhana R. Metastatic spinal cord compression: radiotherapy outcome and dose fractionation.  Radiother Oncol. 2003;  68 175-180
• 26 Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial.  Int J Radiat Oncol Biol Phys. 1995;  32 959-967
• 27 Maranzano E, Latini P, Perrucci E, Beneventi S, Lupattelli M, Corgna E. Short-course radiotherapy (8 Gy x 2) in metastatic spinal cord compression: an effective and feasible treatment.  Int J Radiat Oncol Biol Phys. 1997;  38 1037-1044
• 28 Klimo Jr P, Thompson C J, Kestle J R, Schmidt M H. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease.  Neuro-Oncol. 2004;  7 64-76
• 29 Maranzano E, Latini P, Beneventi S. et al . Comparison of two different radiotherapy schedules for spinal cord compression in prostate cancer.  Tumori. 1998;  84 472-477
• 30 Rades D, Karstens J H, Alberti W. The role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression: a comparison of three different fractionation schedules.  Int J Radiat Oncol Biol Phys. 2002;  54 1160-1164
• 31 Rades D, Stalpers L JA, Hulshof M C. et al . Comparison of 1x8 Gy and 10x3 Gy for functional outcome in patients with metastatic spinal cord compression.  Int J Radiat Oncol Biol Phys. 2005;  62 514-518
• 32 Rades D, Dahm-Daphi J, Rudat V. et al . Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?.  Strahlenther Onkol. 2006;  182 708-712
• 33 Rades D, Fehlauer F, Veninga T. et al . Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.  Int J Radiat Oncol Biol Phys. 2007;  67 532-537
• 34 Rades D, Stalpers L JA, Schulte R. et al . Defining the appropriate radiotherapy regimen for metastatic spinal cord compression (MSCC) in non-small cell lung cancer (NSCLC) patients.  Eur J Cancer. 2006;  42 1052-1056
• 35 Rades D, Stalpers L J, Veninga T, Rudat V, Schulte R, Hoskin P J. Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in prostate cancer patients.  J Urol. 2006;  175 552-556
• 36 Rades D, Veninga T, Stalpers L J. et al . Prognostic factors predicting functional outcome, recurrence-free survival, and overall survival after radiotherapy of metastatic spinal cord compression in breast cancer patients.  Int J Radiat Oncol Biol Phys. 2006;  64 182-188
• 37 Rades D, Walz J, Schild S E, Veninga T, Dunst J. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone?.  Urology. 2007;  69 1081-1085
• 38 Rades D, Walz J, Stalpers L JA. et al . Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study.  Eur Urol. 2006;  49 846-852
• 39 Rades D, Hoskin P J, Stalpers L JA. et al . Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.  Int J Radiat Oncol Biol Phys. 2006;  64 1452-1457
• 40 Rades D, Fehlauer F, Schulte R. et al . Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.  J Clin Oncol. 2006;  24 3388-3393
• 41 Bottke D, Bathe K, Wiegel T, Hinkelbein W. Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck.  Strahlenther Onkol. 2007;  183 128-132
• 42 Kolotas C, Tselis N, Sommerlad M. et al . Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial (192)Ir HDR brachytherapy.  Strahlenther Onkol. 2007;  183 69-75
• 43 Nieder C, Andratschke N, Price R E, Kiang-Ang K. Acceleration of normal tissue damage expression by early stimulation of cell proliferation in rat spinal cord.  Strahlenther Onkol. 2006;  182 680-684
• 44 Joiner M C, Van der Kogel A J. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel GG (ed) Basic clinical radiobiology. New York; Oxford University Press 1997: 106-112
• 45 Rades D, Stalpers L J, Veninga T, Hoskin P J. Spinal reirradiation after short-course RT for metastatic spinal cord compression.  Int J Radiat Oncol Biol Phys. 2005;  63 872-875
• 46 Nieder C, Grosu A L, Andratschke N H, Molls M. Update of human spinal cord reirradiation tolerance based on additional data from 38 patients.  Int J Radiat Oncol Biol Phys. 2006;  66 1446-1449
• 47 Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus J. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy.  Int J Radiat Oncol Biol Phys. 2003;  55 162-167
• 48 Ryu S, Fang Yin F, Rock J. et al . Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis.  Cancer. 2003;  97 2013-2018
• 49 Brown P D, Stafford S L, Schild S E, Martenson J A, Schiff D. Metastatic spinal cord compression in patients with colorectal cancer.  J Neuro-Oncol. 1999;  44 175-180
• 50 Rades D, Dunst J, Schild S E. The first score predicting overall survival in patients with metastatic spinal cord compression.  Cancer. 2008;  112 157-161
• 51 Loblaw D A, Perry J, Chambers A, Laperriere N J. Systematic Review of the Diagnosis and Management of Malignant Extradural Spinal Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group.  J Clin Oncol. 2005;  23 2028-2037
• 52 Sorensen P S, Helweg-Larsen S, Mouridsen H, Hansen H H. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomized trial.  Eur J Cancer. 1994;  30 A 22-27
• 53 Heimdal K, Hirschberg H, Slettebo H, Watne K, Nome O. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression.  J Neurooncol. 1992;  12 141-144
• 54 Rosen L S, Gordon D H, Dugan W. et al . Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion.  Cancer. 2004;  100 36-43
• 55 Rosen L S, Gordon D, Tchekmedyian S. et al . Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase II, double-blind, randomized trial - The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.  J Clin Oncol. 2003;  21 3150-3157
• 56 Saad F, Gleason D M, Murrey R. et al . A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.  J Natl Cancer Inst. 2002;  94 1458-1468
• 57 Aviles A, Fernandez R, Gonzalez J L. et al . Spinal cord compression as a primary manifestation of aggressive malignant lymphomas: long-term analysis of treatments with radiotherapy, chemotherapy or combined therapy.  Leuk Lymphoma. 2002;  43 355-359
• 58 Higgins S A, Peschel R E. Hodgkin's disease with spinal cord compression. A case report and a review of the literature.  Cancer. 1995;  75 94-98
• 59 Wallington M, Mendis S, Premawardhana U, Sanders P, Shahsavar-Haghighi K. Local control and survival in spinal cord compression from lymphoma and myeloma.  Radiother Oncol. 1997;  42 43-47
• 60 Klimo Jr P, Kestle J RW, Schmidt M H. Treatment of metastatic spinal epidural disease: a review of the literature.  Neurosurg Focus. 2003;  15 1-9
• 61 Knisely J, Strugar J. Can decompressive surgery improve outcome in patients with metastatic epidural spinal-cord compression?.  Nat Clin Pract Oncol. 2006;  3 14-15
• 62 Kunkler I. Surgical resection in metastatic spinal cord compression.  Lancet. 2006;  367 109
• 63 Rades D, Veninga T, Stalpers L JA. et al . Excellent outcome after radiotherapy alone for metastatic spinal cord compression (MSCC) in patients with oligometastases.  J Clin Oncol. 2007;  25 50-56